Logo image
The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration
Journal article   Peer reviewed

The 3 Cs of antibiotic allergy—classification, cross-reactivity, and collaboration

J.A. Trubiano, C.A. Stone, M.L. Grayson, K. Urbancic, M.A. Slavin, K.A. Thursky and E.J. Phillips
The Journal of Allergy and Clinical Immunology: In Practice, Vol.5(6), pp.1532-1542
2017
url
Link to Published Version *Subscription may be requiredView

Abstract

Antibiotic allergy labeling is highly prevalent and negatively impacts patient outcomes and antibiotic appropriateness. Reducing the prevalence and burden of antibiotic allergies requires the engagement of key stakeholders such as allergists, immunologists, pharmacists, and infectious diseases physicians. To help address this burden of antibiotic allergy overlabeling, we review 3 key antibiotic allergy domains: (1) antibiotic allergy classification, (2) antibiotic cross-reactivity, and (3) multidisciplinary collaboration. We review the available evidence and research gaps of currently used adverse drug reaction classification systems, antibiotic allergy cross-reactivity, and current and future models of antibiotic allergy care.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.265 Dermatology - Skin Allergies
1.265.1140 Drug Hypersensitivity
Web Of Science research areas
Allergy
Immunology
ESI research areas
Clinical Medicine
Logo image